NCT00221156View on ClinicalTrials.gov

Acarbose and Secondary Prevention After Coronary Stenting

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

April 30, 2009

Conditions
Glucose Metabolism DisordersCoronary Artery Disease
Interventions
DRUG

Acarbose

Trial Locations (3)

650-0047

Institute of Biomedical Research and Innovation., Kobe

Kobe City General Hospital/Institute of Biomedical Research and Innovation, Kobe

701-0192

Kawasaki Medical School Hospital, Kurashiki

All Listed Sponsors
collaborator

Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan

OTHER

collaborator

Kobe City General Hospital

OTHER

lead

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

OTHER

NCT00221156 - Acarbose and Secondary Prevention After Coronary Stenting | Biotech Hunter | Biotech Hunter